These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35112095)

  • 61. Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials.
    D'Ascenzo F; Agostoni P; Abbate A; Castagno D; Lipinski MJ; Vetrovec GW; Frati G; Presutti DG; Quadri G; Moretti C; Gaita F; Zoccai GB
    Atherosclerosis; 2013 Jan; 226(1):178-85. PubMed ID: 23206978
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparing Coronary Atheroma Progression Rates and Coronary Events in the United States, Canada, Latin America, and Europe.
    Puri R; Nicholls SJ; St John J; Tuzcu EM; Kapadia SR; Uno K; Kataoka Y; Wolski K; Nissen SE
    Am J Cardiol; 2016 Dec; 118(11):1616-1623. PubMed ID: 27666179
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction.
    Bayturan O; Puri R; Tuzcu EM; Shao M; Wolski K; Schoenhagen P; Kapadia S; Nissen SE; Sanders P; Nicholls SJ
    Eur J Prev Cardiol; 2017 Mar; 24(4):373-381. PubMed ID: 27837151
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.
    Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lespérance J; Heinonen TM; Kouz S; Berry C; Basser R; Lavoie MA; Guertin MC; Rodés-Cabau J;
    JAMA; 2007 Apr; 297(15):1675-82. PubMed ID: 17387133
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atherosclerosis imaging: intravascular ultrasound.
    Tuzcu EM; Schoenhagen P
    Drugs; 2004; 64 Suppl 2():1-7. PubMed ID: 15765887
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rate of progression of coronary atherosclerotic plaque in women.
    Nicholls SJ; Wolski K; Sipahi I; Schoenhagen P; Crowe T; Kapadia SR; Hazen SL; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2007 Apr; 49(14):1546-51. PubMed ID: 17418293
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study).
    Cheng JM; Oemrawsingh RM; Garcia-Garcia HM; Akkerhuis KM; Kardys I; de Boer SP; Langstraat JS; Regar E; van Geuns RJ; Serruys PW; Boersma E
    Am J Cardiol; 2014 Nov; 114(10):1497-503. PubMed ID: 25248815
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mature proprotein convertase subtilisin/kexin type 9, coronary atheroma burden, and vessel remodeling in heterozygous familial hypercholesterolemia.
    Kataoka Y; Harada-Shiba M; Nakao K; Nakashima T; Kawakami S; Fujino M; Kanaya T; Nagai T; Tahara Y; Asaumi Y; Hori M; Ogura M; Goto Y; Noguchi T; Yasuda S
    J Clin Lipidol; 2017; 11(2):413-421.e3. PubMed ID: 28502498
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound.
    Nicholls SJ; Tuzcu EM; Crowe T; Sipahi I; Schoenhagen P; Kapadia S; Hazen SL; Wun CC; Norton M; Ntanios F; Nissen SE
    J Am Coll Cardiol; 2006 May; 47(10):1967-75. PubMed ID: 16697312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
    Nissen SE; Tsunoda T; Tuzcu EM; Schoenhagen P; Cooper CJ; Yasin M; Eaton GM; Lauer MA; Sheldon WS; Grines CL; Halpern S; Crowe T; Blankenship JC; Kerensky R
    JAMA; 2003 Nov; 290(17):2292-300. PubMed ID: 14600188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.
    Kataoka Y; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    J Am Coll Cardiol; 2012 May; 59(18):1592-7. PubMed ID: 22538329
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques.
    Kataoka Y; Wolski K; Balog C; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1035-41. PubMed ID: 24780871
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
    Nissen SE; Nicholls SJ; Wolski K; Rodés-Cabau J; Cannon CP; Deanfield JE; Després JP; Kastelein JJ; Steinhubl SR; Kapadia S; Yasin M; Ruzyllo W; Gaudin C; Job B; Hu B; Bhatt DL; Lincoff AM; Tuzcu EM;
    JAMA; 2008 Apr; 299(13):1547-60. PubMed ID: 18387931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.
    Makover ME; Shapiro MD; Toth PP
    Am J Prev Cardiol; 2022 Dec; 12():100371. PubMed ID: 36124049
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of statins on serial coronary calcification during atheroma progression and regression.
    Puri R; Nicholls SJ; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nissen SE
    J Am Coll Cardiol; 2015 Apr; 65(13):1273-1282. PubMed ID: 25835438
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation).
    Nicholls SJ; Tuzcu EM; Brennan DM; Tardif JC; Nissen SE
    Circulation; 2008 Dec; 118(24):2506-14. PubMed ID: 19029466
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors.
    Horikoshi T; Obata JE; Nakamura T; Fujioka D; Watanabe Y; Nakamura K; Watanabe K; Saito Y; Kugiyama K
    J Atheroscler Thromb; 2019 Dec; 26(12):1062-1074. PubMed ID: 30996201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.